Skip to main content
. 2022 Jun 20;40(32):4603–4608. doi: 10.1016/j.vaccine.2022.06.039

Table 2.

Symptoms and vaccine lesion progression.

BCG Placebo
p
BCG
Placebo
p
BCG
Placebo
p
BCG
Placebo
p
BCG
Placebo
p
N(%) T0 T1 T2 T3 T4
Cough 54(36.5) 42(27.8) 0.141 33(22.3) 30(19.9) 0.671 24(16.2) 17(11.3) 0.241 18(12.2) 10(6.6) 0.111 14(9.5) 9(6) 0.281
Fever 2(1.4) 1(0.7) 0.621 0(0) 1(0.7) 11 0(0) 0(0) 0(0) 0(0) 0(0) 0(0)
Chills 6(4.1) 4(2.6) 0.531 1(0.7) 2(1.3) 11 0(0) 1(0.7) 11 0(0) 1(0.7) 11 0(0) 0(0)
Fatigue 46(31.1) 53(35.1) 0.461 24(16.2) 22(14.6) 0.751 24(16.2) 13(8.6) 0.0541 20(13.5) 8(5.3) 0.0171 16(10.8) 15(9.9) 0.851
OR = 0.49 (0.22 – 1.05) OR = 0.36 (0.13–0.89)
Coryza 12(8.1) 9(6.0) 0.501 5(3.4) 7(4.6) 0.771 8(5.4) 7(4.6) 0.801 6(4.1) 2(1.3) 0.171 4(2.7) 3(2.0) 0.721
Nasal Congestion 22 (14.9) 23 (15.2) 11 8(5.4) 11(7.3) 0.641 6(4.1) 7(4.6) 11 3(2.0) 4(2.6) 11 1(0.7) 3(2.0) 0.621
Myalgia 23(15.5) 28(18.5) 0.541 13(8.8) 21(13.9) 0.201 4(2.7) 12(7.9) 0.0691 10(6.8) 7(4.6) 0.461 5(3.4) 3(2.0) 0.501
Arthralgia 14(9.5) 15(9.9) 11 3(2.0) 11(7.3) 0.0521 1(0.7) 5(3.3) 0.211 3(2.0) 3(2.0) 11 1(0.7) 4(2.6) 0.371
Headache 31(20.9) 31(20.5) 11 24(16.2) 28(18.5) 0.651 16(10.8) 16(10.6) 11 14(9.5) 11(7.3) 0.531 18(12.2) 9(6.0) 0.071
Sore throat 16(10.8) 23(15.2) 0.301 9(6.1) 7(4.6) 0.621 5(3.4) 4(2.6) 0.741 4(2.7) 6(4.0) 0.751 0(0) 3(2.0) 0.241
Anosmia 70(47.3) 63(41.7) 0.351 38(25.7) 56(37.1) 0.0351 32(21.6) 37(24.5) 0.591 23(15.5) 30(19.9) 0.371 16(10.8) 26(17.2) 0.141
OR = 1.70 (1.01–2.89)
Ageusia 59 (39.9) 49 (32.5) 0.191 35(23.6) 43(28.5) 0.361 25(16.9) 31(20.5) 0.461 24(16.2) 24(15.9) 11 12(8.1) 18(11.9) 0.341
Nausea 9(6.1) 10(6.6) 11 2(1.4) 4(2.6) 0.681 1(0.7) 1(0.7) 11 1(0.7) 1(0.7) 11 1(0.7) 0(0) 0.501
Vomiting 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 1(0.7) 0(0) 0.501 0(0) 0(0)
Diarrhea 13(8.8) 5(3.3) 0.0541 3(2.0) 4(2.6) 11 4(2.7) 1(0.7) 0.211 2(1.4) 1(0.7) 0.621 2(1.4) 0(0) 0.241
Chest pain 11(7.4) 7 (4.6) 0.341 4(2.7) 2(1.3) 0.441 1(0.7) 3(2.0) 0.621 1(0.7) 1(0.7) 11 2(1.4) 1(0.7) 0.621
Dyspnea 20(13.5) 14(9.3) 0.281 12(8.1) 4(2.6) 0.0421 6(4.1) 5(3.3) 0.771 3(2.0) 4(2.6) 11 4(2.7) 2(1.3) 0.441
OR = 0.31 (0.07 – 1.05)
Somnolence 13 (8.8) 17(11.3) 0.571 8(5.4) 5(3.3) 0.411 5(3.4) 5(3.3) 11 3(2.0) 2(1.3) 0.681 3(2.0) 3(2.0) 11
Mental confusion 4(2.7) 2(1.3) 0.441 2(1.4) 1(0.7) 0.621 1(0.7) 1(0.7) 11 1(0.7) 1(0.7) 11 1(0.7) 3(2.0) 0.621
Median number of symptoms 2 2 0.451 1 1 0.101 1 1 0.981 0 0 0.361 0 0 0.881
Vaccine lesion
Erythema 122(82.4) 1(0.7) <0.00011 117(79.1) 2(1.3) <0.00011 106(71.6) 3(2.0) <0.00011 90(60.8) 0(0) <0.00011
Erythema size 11.4 ± 5.9 5.0 10.6 ± 4.2 1.0 ± 1.4 10.0 ± 5.1 3.0 ± 1.0 7.2 ± 3.0
Papule 93(62.8) 1(0.7) <0.00011 60(40.5) 3(2.0) <0.00011 55(37.2) 1(0.7) <0.00011 23(15.5) 0(0) <0.00011
Papule size 10.4 ± 5.4 5.0 9.2 ± 2.8 1.5 ± 2.1 9.2 ± 5.4 4.0 6.9 ± 3.9
Pustule 12(8.1) 1(0.7) 0.00141 28(18.9) 0(0) <0.00011 10(6.8) 0(0) 0.00081 6(4.1) 0(0) 0.0141
Pustule size 13.4 ± 6.9 2.5 11.9 ± 5.2 9.6 ± 3.3 7.0 ± 9.9
Local Pain 9(6.1) 0(0) 0.00161 6(4.1) 0(0) 0.0141 7(4.7) 0(0) 0.00681 0(0) 0(0)
Pain size 13.2 ± 6.3 11.0 ± 1.4 9.6 ± 4.0 8.3 ± 3.6 5.0
Itching 19(12.8) 0(0) <0.00011 11(7.4) 0(0) 0.00031 12(8.1) 0(0) 0.00021 7(4.7) 0(0) 0.0071
Itching size 10.1 ± 5
0.5
10.3 ± 0.8 11.4 ± 5.7 7.0 ± 1.2
Ulcer 0(0) 0(0) 2(1.4) 0(0) 0.241 6(4.1) 0(0) 0.0141 7(4.7) 0(0) 0.0071
Ulcer size 15 ± 0 8.7 ± 2.5 7.4 ± 1.4
Crust 3(2.0) 0(0) 0.121 13(8.8) 0(0) <0.00011 19(12.8) 0(0) <0.00011 33(22.3) 0(0) <0.00011
Crust size 25 ± 0 8.9 ± 2.4 9.6 ± 1.6 7.0 ± 2.0
Scar 0(0) 0(0) 1(0.7) 0(0) 0.501 4(2.7) 2(1.3) 0.441 33(22.3) 0(0) <0.00011
Scar size 10 11.7 ± 11.7 3.0 ± 0 6.7 ± 2.0
Peeling 2(1.4) 0(0) 0.241 12(8.1) 0(0) 0.00021 16(10.8) 0(0) <0.00011 32(21.6) 0(0) <0.00011
Peeling size 12 11.0 ± 2.5 10.1 ± 5.5 7.6 ± 3.0
Vesicle 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0)
Lymphadenopathy 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0)
Lesion size overall 10.6 ± 6.4 3.3 ± 1.5 10.5 ± 4.2 3.8 ± 1.5 9.7 ± 4.9 3.3 ± 1.0 6.8 ± 2.9 2.0

Legend: 1Wilcoxon rank sum test; p = p-value; BCG = Bacillus Calmette-Guérin; N = number of participants.